Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy

Validation of Doppler Ultrasound, CT Parameters Versus Laparoscopic Scoring in Assessment of Suspicious Ovarian Malignancy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06109545

Enrollment

Registered

2023-10-31

Start date

2023-06-24

Completion date

2025-06-01

Last updated

2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

Ovarian cancer, Doppler, CT, Laparoscopy

Brief summary

The aim of this study is to assess validation of ultrasound (± Doppler) parameters in the diagnosis of suspicious ovarian malignant tumors and laparoscopic assessment of these findings according to Fagotti score evaluation of suspicious malignant tumors

Detailed description

The aim of this study is to asses validation of ultrasound (± Doppler) parameters in the diagnosis of suspicious ovarian malignant tumors and laparoscopic assessment of these findings according to Fagotti score evaluation of suspicious malignant tumors

Interventions

PROCEDURELaparoscopy

Patients included in this study will have diagnostic laparoscopy type WOLF done after checking all above ultrasound parameters of malignant tumor. This procedure will be done under general anathesia then a verses needle will be used at umbilicus or at palmer point if the mass is large or in cases of umbilical hernia or previous abdominal or pelvic surgery, then Fagotti criteria will be assessed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 75 Years

Inclusion criteria

1. all patients with clinical or radiological suspicion of ovarian cancer. 2. at least one of clinical presentation of suspected or advanced ovarian cancer and performed ultrasound or CT or MRI that detect a pelvic mass and CA125 is more than 200 UL/ML. 3. patients with eastern Cooperative Oncology Group status from 0 to 3.

Exclusion criteria

1. the women outside the age group in our study. 2. any known malignancy at other sites. 3. uncompliant patients who have severed uncontrolled infection or any other medical problem. 4. any previous major surgery. 5. patients who refuse to give an informed consent to do laparoscopy. 6. pregnancy and its complications.

Design outcomes

Primary

Measure	Time frame	Description
Fagotti score	Al time of laparoscopy	Laparoscopic staging of suspicious ovarian mass

Countries

Egypt

Contacts

Primary ContactSarah Madany, MSc

sarahmadany20@gmail.com+201027991297

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026